Vecuronium
- Level
- Commodity
- Parent
- 51152000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51152004This classification denotes a nicotinic antagonist with the molecular formula C34H57N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5438723848, chemically known as 5alpha-androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetate but generally known as vecuronium, which bears US NIH Compound Identifier 39764. European Medicines Agency schedules Vecuronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05084MIG. World Health Organization schedules vecuronium in its Anatomical Therapeutic Chemical (ATC) Classification. VECURONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, VECURONIUM remains the US FDA Preferred Term for this commodity. Vecuronium bears US NLM identifiers UMLS ID C0242531 and NCI Concept Code C87317. SMILES: BR.O(C1C2(C(C3C(C4(C(CC3)CC(OC(=O)C)C(N3CCCCC3)C4)C)CC2)CC1[N]1(CCCCC1)C)C)C(=O)C.
Same parent
Under 51152000 · 74Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.